Items Tagged ‘Gist’

April 26th, 2017

SWOG Study Shows Strong Long-Term Survival Rates for Patients with GIST

By

PORTLAND, OR – Nine years ago, SWOG researchers confirmed a new standard of care for patients with incurable gastrointestinal stromal tumors (GIST), who could survive by being treated with imatinib mesylate, the breakthrough drug marketed as Gleevec. SWOG researchers are back with long-term findings from that study, which estimate that nearly one in four patients treated with […]

View full entry

Tags: clinical trial archive gist, Gastrointestinal Stromal Tumors, Gist, News